← Leaderboards
Cong Yan
Indiana University Indianapolis
$8,041,133
Attributed
$9,366,653
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $670.5K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,366,653 · 5
By mechanism
R01$9,366,653 · 5
Top collaborators
- Hong Du5 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Hong Du$3,554,244
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryInflammationMouse ModelMolecularCellsPlayRespiratory EpitheliumLaboratory MouseTranscription FactorNonesterified Fatty AcidsCholesterolAcid LipaseIn VivoSignal TransductionBloodLigandsNeoplasm MetastasisKnock-OutMyelogenousBone MarrowCholesterol EstersImmunotherapyMyeloid CellsNeoplastic Cell
Grant awards (28)
Metabolic Regulation ofPD-L1 in CD11c+ Cells$520,593
R01 · FY2023 · CA · contact PI
Metabolic Regulation ofPD-L1 in CD11c+ Cells$520,593
R01 · FY2022 · CA · contact PI
Metabolic Regulation ofPD-L1 in CD11c+ Cells$531,218
R01 · FY2021 · CA · contact PI
Metabolic Regulation ofPD-L1 in CD11c+ Cells$531,218
R01 · FY2020 · CA · contact PI
Metabolic Regulation ofPD-L1 in CD11c+ Cells$547,418
R01 · FY2019 · CA · contact PI
Inflammation and Immunosuppression in Lung Cancer$309,328
R01 · FY2015 · CA · contact PI
Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers$333,241
R01 · FY2014 · CA · contact PI
Inflammation and Immunosuppression in Lung Cancer$300,048
R01 · FY2014 · CA · contact PI
Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers$322,933
R01 · FY2013 · CA · contact PI
Inflammation and Immunosuppression in Lung Cancer$290,768
R01 · FY2013 · CA · contact PI
Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers$343,545
R01 · FY2012 · CA · contact PI
Inflammation and Immunosuppression in Lung Cancer$309,328
R01 · FY2012 · CA · contact PI
Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers$343,545
R01 · FY2011 · CA · contact PI
Inflammation and Immunosuppression in Lung Cancer$318,512
R01 · FY2011 · CA · contact PI
Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers$449,578
R01 · FY2010 · CA · contact PI
Nuclear Receptor Co-Activators in the Lung$370,331
R01 · FY2006 · HL · contact PI
Genetic Control of SP-B Gene Expression in the Lung$295,581
R01 · FY2006 · HL · contact PI
Nuclear Receptor Co-Activators in the Lung$278,630
R01 · FY2005 · HL
Genetic Control of SP-B Gene Expression in the Lung$230,950
R01 · FY2005 · HL
Nuclear Receptor Co-Activators in the Lung$93,870
R01 · FY2005 · HL
Genetic Control of SP-B Gene Expression in the Lung$67,050
R01 · FY2005 · HL
Nuclear Receptor Co-Activators in the Lung$372,500
R01 · FY2004 · HL
Genetic Control of SP-B Gene Expression in the Lung$293,100
R01 · FY2004 · HL
Nuclear Receptor Co-Activators in the Lung$372,500
R01 · FY2003 · HL
Genetic Control of SP-B Gene Expression in the Lung$315,650
R01 · FY2003 · HL
RETINOIC ACID RECEPTOR AND SP-B GENE REGULATION$241,851
R01 · FY2002 · HL
RETINOIC ACID RECEPTOR AND SP-B GENE REGULATION$234,806
R01 · FY2001 · HL
RETINOIC ACID RECEPTOR AND SP-B GENE REGULATION$227,968
R01 · FY2000 · HL